Ocular Surface Erosion of a Vaccine for SARS-CoV2 (COVID-19 virus)

Completed

• Conditions: Healthy person; COVID-19, Vaccine; Ocular surface; Cornea

• Registration Number: TCTR20210510008
• Lead Sponsor: Rajavithi Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-04-07
• Study Start: 2021-05-10
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Healthy person who exposure to vaporized solution of a vaccine for SARS-CoV2

Exclusion Criteria

None

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Ocular surface grading 1 week Oxford grading scale

Secondary Outcome Measures

Name	Time	Method
Side effect 1 month Ocular side effect